ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD), sponsored by ARYA Sciences Holdings IV and backed by healthcare-focused investment firm Perceptive Advisors, is a blank-check company targeting the life sciences and biotechnology sector. The company completed its initial public offering in 2021 and filed its annual report on Form 10-K with the SEC in April 2023, reflecting its continued search for a qualifying business combination target at that time. ARYD is the fourth vehicle in the ARYA Sciences SPAC series, establishing the sponsor as a repeat issuer within the healthcare and biopharma space. For complete filings, deal timelines, and target analytics on ARYD and hundreds of other SPACs, sign up for full data access at SpacDesk.